Platinum based cancer drugs market

1. Platinum Based Cancer Drugs Market
Set to Exceed $ 1,814.1
Mn By 2026
| CAGR 4.1%

2. Platinum Based Cancer Drugs Market Size Worth $ 1,814.1Mn By 2026
- 2 -
“ Global Platinum Based Cancer Drugs Market Share, Size, Trends, Industry
Analysis Report By Drug Type (Cisplatin, Oxaliplatin, Carboplatin, Other),
By Application (Colorectal Cancer, Ovarian Cancer, Lung Cancer, Other); By
Regions, and Segment Forecast, 2019 – 2026”
The global platinum based Cancer drugs market size is expected to reach USD 1,814.1 Million by 2026
according to a new study by Polaris Market Research. The report “Global Platinum Based Cancer
Drugs Market Share, Size, Trends, Industry Analysis Report By Drug Type (Cisplatin, Oxaliplatin,
Carboplatin, Other), Application (Colorectal, Ovarian, Lung, & Other Cancer); By Regions,
Segments & Forecast, 2019 – 2026”gives a detailed insight into current market dynamics and provides
analysis on future market growth.
Browse Detailed Research Report On Platinum Based Cancer Drugs Market Analysis:
https://www.polarismarketresearch.com/industry-analysis/platinum-based-cancer-drugs-
market
Drugs based on platinum have become a major component of cancer therapy; about half of all patients
undergoing chemotherapy receive a platinum drug. The widespread use of platinum agents in cancer
treatment started with Barnett Rosenberg’s discovery of cisplatin’s antineoplastic activity in the 1960s.
According to the National Cancer Institute, the instances of new cases per year is expected to rise to 23.6
million by 2030. Nevertheless, the major limitations of this industry worldwide are the drug-related side
effects and resistance growth. Recent developments in platinum based cancer drugs include the
development of analog platinum drugs such as platinum carrier molecule complexes to boost targeted
concentration of drugs in cancer tumor. This increasing number of cancer instances is expected to drive
the growth of the global platinum cancer drug market during the forecast period.
Due to enhanced disease prevalence, enhanced awareness, increased per capita income, and enhanced
health care infrastructure, the Asia Pacific market is anticipated to develop at the largest CAGR. North
America dominated the global market in 2018 due to the high incidence of cancer in the region,
developments in these drugs and recent FDA approvals. United States is the world’s largest drug market.

3. Platinum Based Cancer Drugs Market Size Worth $ 1,814.1Mn By 2026
- 3 -
This has led to the dominance of North America in the global platinum cancer drug market. The U.S.
pharmaceutical industry is the largest domestic market in the world. It is the world’s biggest continental
pharmaceutical market together with Canada and Mexico. More than 45 percent of the worldwide
pharmaceutical industry is held by the United States alone. This share was valued at approximately $446
Million in 2016. Many of the top worldwide firms are from the U.S. In 2016, six out of the top 10 firms were
based on sheer pharmaceutical income from the United States.
Major players in the platinum cancer drug market include Sanofi, Pfizer, Inc., Mylan N.V., Ask-Pharma, Sun
Pharmaceutical Industries Ltd., Accord Healthcare, Novartis AG, Teva Pharmaceutical Industries Ltd.,
Guizhou YiBai Pharmaceutical Co., Ltd., SK Chemicals, Qilu Pharmaceutical Co., Ltd., Dr. Reddy’s
Laboratories Ltd., Debiopharm Group, and Jiangsu Hengrui Pharmaceutical Co., Ltd.
Request for sample: https://www.polarismarketresearch.com/industry-analysis/platinum-
based-cancer-drugs-market/request-for-sample
Table of Contents
1. Platinum Based Cancer Drugs Market Size and Forecast by Drug Type
1.1. Global Platinum Based Cancer Drugs market share by Drug Type, 2018 & 2026
1.2. Cisplatin
1.2.1. Global cisplatin Platinum Based Cancer Drugs market estimates and forecasts,
2015 - 2026 (USD Million)
1.2.2. Global cisplatin Platinum Based Cancer Drugs market estimates and forecasts, by
region, 2015 - 2026 (USD Million)
1.3. Oxaliplatin
1.3.1. Global oxaliplatin Platinum Based Cancer Drugs market estimates and forecasts,
2015 - 2026 (USD Million)
1.3.2. Global oxaliplatin Platinum Based Cancer Drugs market estimates and forecasts,
by region, 2015 - 2026 (USD Million)
1.4. Carboplatin
1.4.1. Global carboplatin Platinum Based Cancer Drugs market estimates and forecasts,
2015 - 2026 (USD Million)
1.4.2. Global carboplatin Platinum Based Cancer Drugs market estimates and forecasts,
by region, 2015 - 2026 (USD Million)
1.5. Others
1.5.1. Global other Platinum Based Cancer Drugs market estimates and forecasts, 2015
- 2026 (USD Million)
1.5.2. Global other Platinum Based Cancer Drugs market estimates and forecasts, by
region, 2015 - 2026 (USD Million)
2. Platinum Based Cancer Drugs Market Size and Forecast by Application
2.1. Global Platinum Based Cancer Drugs market share by application, 2018 & 2026
2.2. Colorectal Cancer
2.2.1. Global Platinum Based Cancer Drugs market estimates and forecasts for
colorectal cancer, 2015 - 2026 (USD Million)
2.2.2. Global Platinum Based Cancer Drugs market estimates and forecasts for
colorectal cancer, by region, 2015 - 2026 (USD Million)
2.3. Ovarian Cancer
2.3.1. Global Platinum Based Cancer Drugs market estimates and forecasts for ovarian
cancer, 2015 - 2026 (USD Million)
2.3.2. Global Platinum Based Cancer Drugs market estimates and forecasts for ovarian
cancer, by region, 2015 - 2026 (USD Million)
2.4. Lung Cancer

4. Platinum Based Cancer Drugs Market Size Worth $ 1,814.1Mn By 2026
- 4 -
2.4.1. Global Platinum Based Cancer Drugs market estimates and forecasts for lung
cancer, 2015 - 2026 (USD Million)
2.4.2. Global Platinum Based Cancer Drugs market estimates and forecasts for lung
cancer, by region, 2015 - 2026 (USD Million)
2.5. Others
2.5.1. Global Platinum Based Cancer Drugs market estimates and forecasts for others,
2015 - 2026 (USD Million)
2.5.2. Global Platinum Based Cancer Drugs market estimates and forecasts for others,
by region, 2015 - 2026 (USD Million)
3. Platinum Based Cancer Drugs Market Size and Forecast by Region
3.1. Global Platinum Based Cancer Drugs market share by region, 2018 & 2026
3.2. North America
3.2.1. North America Platinum Based Cancer Drugs market by Drug Type (USD Million),
2015 - 2026
3.2.2. North America Platinum Based Cancer Drugs market by application type (USD
Million), 2015 - 2026
3.2.3. U.S.
3.2.3.1. U.S. Platinum Based Cancer Drugs market by Drug Type (USD Million),
2015 - 2026
3.2.3.2. U.S. Platinum Based Cancer Drugs market by application type (USD
Million), 2015 - 2026
3.2.4. Canada
3.2.4.1. Canada Platinum Based Cancer Drugs market by Drug Type (USD
Million), 2015 - 2026
3.2.4.2. Canada Platinum Based Cancer Drugs market by application type (USD
Million), 2015 - 2026
3.3. Europe
3.3.1. Europe Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 -
2026
3.3.2. Europe Platinum Based Cancer Drugs market by application type (USD Million),
2015 - 2026
3.3.3. Germany
3.3.3.1. Germany Platinum Based Cancer Drugs market by Drug Type (USD
Million), 2015 - 2026
3.3.3.2. Germany Platinum Based Cancer Drugs market by application type (USD
Million), 2015 - 2026
3.3.4. UK
3.3.4.1. UK Platinum Based Cancer Drugs market by Drug Type (USD Million),
2015 - 2026
3.3.4.2. UK Platinum Based Cancer Drugs market by application type (USD
Million), 2015 - 2026
3.3.5. France
3.3.5.1. France Platinum Based Cancer Drugs market by Drug Type (USD Million),
2015 - 2026
3.3.5.2. France Platinum Based Cancer Drugs market by application type (USD
Million), 2015 - 2026
3.3.6. Italy
3.3.6.1. Italy Platinum Based Cancer Drugs market by Drug Type (USD Million),
2015 - 2026
3.3.6.2. Italy Platinum Based Cancer Drugs market by application type (USD
Million), 2015 - 2026

5. Platinum Based Cancer Drugs Market Size Worth $ 1,814.1Mn By 2026
- 5 -
3.3.7. Russia
3.3.7.1. Russia Platinum Based Cancer Drugs market by Drug Type (USD Million),
2015 - 2026
3.3.7.2. Russia Platinum Based Cancer Drugs market by application type (USD
Million), 2015 - 2026
3.4. Asia Pacific
3.4.1. Asia Pacific Platinum Based Cancer Drugs market by Drug Type (USD Million),
2015 - 2026
3.4.2. Asia Pacific Platinum Based Cancer Drugs market by application type (USD
Million), 2015 - 2026
3.4.3. China
3.4.3.1. China Platinum Based Cancer Drugs market by Drug Type (USD Million),
2015 - 2026
3.4.3.2. China Platinum Based Cancer Drugs market by application type (USD
Million), 2015 - 2026
3.4.4. South Korea
3.4.4.1. South Korea Platinum Based Cancer Drugs market by Drug Type (USD
Million), 2015 - 2026
3.4.4.2. South Korea Platinum Based Cancer Drugs market by application type
(USD Million), 2015 - 2026
3.4.5. Japan
3.4.5.1. Japan Platinum Based Cancer Drugs market by Drug Type (USD Million),
2015 - 2026
3.4.5.2. Japan Platinum Based Cancer Drugs market by application type (USD
Million), 2015 - 2026
3.4.6. India
3.4.6.1. India Platinum Based Cancer Drugs market by Drug Type (USD Million),
2015 - 2026
3.4.6.2. India Platinum Based Cancer Drugs market by application type (USD
Million), 2015 - 2026
3.5. Latin America
3.5.1. Latin America Platinum Based Cancer Drugs market by Drug Type (USD Million),
2015 - 2026
3.5.2. Latin America Platinum Based Cancer Drugs market by application type (USD
Million), 2015 - 2026
3.5.3. Brazil
3.5.3.1. Brazil Platinum Based Cancer Drugs market by Drug Type (USD Million),
2015 - 2026
3.5.3.2. Brazil Platinum Based Cancer Drugs market by application type (USD
Million), 2015 - 2026
3.5.4. Mexico
3.5.4.1. Mexico Platinum Based Cancer Drugs market by Drug Type (USD Million),
2015 - 2026
3.5.4.2. Mexico Platinum Based Cancer Drugs market by application type (USD
Million), 2015 - 2026
3.5.5. Colombia
3.5.5.1. Colombia Platinum Based Cancer Drugs market by Drug Type (USD
Million), 2015 - 2026
3.5.5.2. Colombia Platinum Based Cancer Drugs market by application type (USD
Million), 2015 - 2026
3.6. Middle East & Africa

6. Platinum Based Cancer Drugs Market Size Worth $ 1,814.1Mn By 2026
- 6 -
3.6.1. MEA Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 -
2026
3.6.2. MEA Platinum Based Cancer Drugs market by application type (USD Million),
2015 - 2026
3.6.3. Saudi Arabia
3.6.3.1. Saudi Arabia Platinum Based Cancer Drugs market by Drug Type (USD
Million), 2015 - 2026
3.6.3.2. Saudi Arabia Platinum Based Cancer Drugs market by application type
(USD Million), 2015 - 2026
3.6.4. South Africa
3.6.4.1. South Africa Platinum Based Cancer Drugs market by Drug Type (USD
Million), 2015 - 2026
3.6.4.2. South Africa Platinum Based Cancer Drugs market by application type
(USD Million), 2015 - 2026
3.6.5. Israel
3.6.5.1. Israel Platinum Based Cancer Drugs market by Drug Type (USD Million),
2015 - 2026
3.6.5.2. Israel Platinum Based Cancer Drugs market by application type (USD
Million), 2015 - 2026
3.6.6. UAE
3.6.6.1. UAE Platinum Based Cancer Drugs market by Drug Type (USD Million),
2015 - 2026
3.6.6.2. UAE Platinum Based Cancer Drugs market by application type (USD
Million), 2015 - 2026
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company
specializes in providing exceptional market intelligence and in-depth business research services for
our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse
customer base present across the industries of healthcare, technology, semi-conductors and
chemicals among various other industries present around the world. We strive to provide our
customers with updated information on innovative technologies, high growth markets, emerging
business environments and latest business-centric applications, thereby helping them always to make
informed decisions and leverage new opportunities. Adept with a highly competent, experienced and
extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris
endeavor to deliver value-added business solutions to our customers.
E mail Id: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com